Skip to main content
SpringerLink
Log in

Involvement of sulfate conjugation and multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of garenoxacin in rats

  • Original Article
  • Published:
Journal of Infection and Chemotherapy

Abstract

In this study, the involvement of sulfate conjugation and drug efflux transporter multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of a new quinolone antimicrobial agent, garenoxacin, was investigated in Sprague–Dawley (SD) rats and Eisai hyperbilirubinemic rats (EHBRs) lacking Mrp2. The disappearance of garenoxacin from plasma in female SD rats was significantly faster than that in male SD rats after a single intravenous injection of garenoxacin (5 mg/kg). The systemic clearance of garenoxacin in female rats was approximately threefold larger than that of male rats (2.43 ± 0.31 and 0.87 ± 0.06 l/h/kg, respectively), suggesting the existence of sex-related differences in the pharmacokinetics of garenoxacin. When rats received a constant-rate infusion of garenoxacin, the contribution of biliary and renal excretion of garenoxacin was small, and no significant difference in the biliary (CLBILE) clearance of garenoxacin was observed between male and female SD rats. The metabolic clearance [CLM (SULF)] of garenoxacin to garenoxacin sulfate conjugate (which is mainly excreted into the bile) in female SD rats was 8.5-fold larger than that in male SD rats (27.9 ± 2.94 and 3.28 ± 0.07 ml/h/kg, respectively). The CLBILE of garenoxacin was decreased in male and female EHBRs by approximately 50% compared with that in male and female SD rats. These results suggest that sulfate conjugation, but not Mrp2, is mainly involved in the sex-related differences in the pharmacokinetics of garenoxacin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hayakawa H, Fukushima Y, Kato H, Fukumoto H, Kadota T, Yamamoto H, et al. Metabolism and disposition of novel des-fluoro quinolone garenoxacin in experimental animals and interspecies scaling of pharmacokinetic parameters. Drug Metab Dispos. 2003;31:1409–18.

    Article  CAS  PubMed  Google Scholar 

  2. Kato H, Hayakawa H, Fukushima Y, Kadota T, Fukumoto H, Todo Y. Pharmacokinetics of garenoxacin in laboratory animal species. Jpn J Chemother. 2007;55(S-1):78–86.

    CAS  Google Scholar 

  3. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA. 1987;84:7735–8.

    Article  CAS  PubMed  Google Scholar 

  4. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 1996;97:2517–24.

    Article  CAS  PubMed  Google Scholar 

  5. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smith JJ, et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA. 1997;94:4028–32.

    Article  CAS  PubMed  Google Scholar 

  6. Oude Elferink RP, Meijer DK, Kuipers F, Jansen PL, Groen AK, Groothuis GM. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta. 1995;1241:215–68.

    PubMed  Google Scholar 

  7. Cormet-Boyaka E, Huneau JF, Mordrelle A, Boyaka PN, Carbon C, Rubinstein E, et al. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob Agents Chemother. 1998;42:2607–11.

    CAS  PubMed  Google Scholar 

  8. Murata M, Tamai I, Kato H, Nagata O, Kato H, Tsuji A. Efflux transport of a new quinolone antimicrobial agent, HSR-903, across the blood–brain barrier. J Pharmacol Exp Ther. 1999;290:51–7.

    CAS  PubMed  Google Scholar 

  9. De Lange ECM, Marchand S, van den Berg DJ, van der Sandt ICJ, de Boer A, Delon GA, et al. In vitro and in vivo investigations on fluoroquinolones: effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin. Eur J Pharm Sci. 2000;12:85–95.

    Article  PubMed  Google Scholar 

  10. Tamai I, Yamashita J, Kido Y, Ohnari A, Sai Y, Shima Y, et al. Limited distribution of new quinolone antimicrobial agents into brain caused by multiple efflux transporters at the blood–brain barrier. J Pharmacol Exp Ther. 2000;295:146–52.

    CAS  PubMed  Google Scholar 

  11. Naruhashi K, Tamai I, Inoue N, Muraoka H, Sai Y, Suzuki N, et al. Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P-glycoprotein. J Pharm Pharmacol. 2001;53:699–709.

    Article  CAS  PubMed  Google Scholar 

  12. Yamaguchi H, Yano I, Saito H, Inui K. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo. J Pharmacol Exp Ther. 2002;300:1063–9.

    Google Scholar 

  13. Zhao YL, Cai SH, Wang L, Kitaichi K, Tatsumi Y, Nadai M, et al. Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin. Clin Exp Pharmacol Physiol. 2002;29:167–72.

    Article  CAS  PubMed  Google Scholar 

  14. Shimizu A, Miyoshi M, Sugie M, Ueyama J, Yamaguchi T, Sasaki T, et al. Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats. Eur J Pharmacol. 2004;501:151–9.

    Article  CAS  PubMed  Google Scholar 

  15. Sasabe H, Tsuji A, Sugiyama Y. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. J Pharmacol Exp Ther. 1998;284:1033–9.

    CAS  PubMed  Google Scholar 

  16. Takenaka O, Horie T, Kobayashi K, Suzuki H, Sugiyama Y. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia. Pharm Res. 1995;12:1746–55.

    Article  CAS  PubMed  Google Scholar 

  17. Yamazaki K, Mikami T, Hosokawa S, Tagaya O, Nozaki Y, Kawaguchi A, et al. A new mutant rat with hyperbilirubinemia (hyb). J Hered. 1995;86:314–7.

    CAS  PubMed  Google Scholar 

  18. Ishikawa T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci. 1992;17:463–8.

    Article  CAS  PubMed  Google Scholar 

  19. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T, Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol. 1997;272:G16–22.

    CAS  PubMed  Google Scholar 

  20. Paulusma CC, Oude Elferink RP. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man. J Mol Med. 1997;75:420–8.

    Article  CAS  PubMed  Google Scholar 

  21. Johnson DR, Guo GL, Klaassen CD. Expression of rat multidrug resistance protein 2 (Mrp2) in male and female rats during normal and pregnenolone-16α-carbonitrile (PCN)-induced postnatal ontogeny. Toxicology. 2002;178:209–19.

    Article  CAS  PubMed  Google Scholar 

  22. Suzuki T, Zhao YL, Nadai M, Naruhashi K, Shimizu A, Takagi K, et al. Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats. Life Sci. 2006;79:455–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are extremely grateful to Toyama Chemical Co., Ltd. (Toyama, Japan) for its generous contribution of drugs. This work was supported in part by a grant-in-aid for scientific research (20590587) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

  1. Department of Pharmacy and Pharmacokinetics, Aichi Medical University School of Medicine, 21 Karimata, Yazako, Nagakute-cho, Aichi-gun, Aichi, 480-1195, Japan

    Tamon Hayashi, Fumie Abe, Miki Kato, Hiroko Saito & Takaaki Hasegawa

  2. Department of Medical Technology, Nagoya University School of Health Sciences, 1-1-20 Daikominami, Higashi-ku, Nagoya, 461-8673, Japan

    Jun Ueyama

  3. Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpaku-ku, Nagoya, 468-8503, Japan

    Yuya Kondo, Kuniyuki Imai, Miki Katoh & Masayuki Nadai

Authors
  1. Tamon Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fumie Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miki Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroko Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun Ueyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuya Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kuniyuki Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Miki Katoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masayuki Nadai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Takaaki Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takaaki Hasegawa.

About this article

Cite this article

Hayashi, T., Abe, F., Kato, M. et al. Involvement of sulfate conjugation and multidrug resistance-associated protein 2 (Mrp2) in sex-related differences in the pharmacokinetics of garenoxacin in rats. J Infect Chemother 17, 24–29 (2011). https://doi.org/10.1007/s10156-010-0095-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-010-0095-z

Keywords

Search

Navigation